Key Highlights

  • ALS runs laboratories that test samples for miners and for environmental and life-sciences clients, linking its Revenue to their spending.
  • FY2026 revenue rose 10.7% to A$3,320.1 million and underlying net profit rose 25.8% to A$381.2 million.
  • Its Commodities division, tied to mineral exploration, expanded margins above 30% for a fifth consecutive year.
  • ALS Limited (ASX:ALQ) is a global testing, inspection and certification company and a member of the S&P/ASX 200 industrials sector.

ALS Limited (ASX:ALQ) is a global testing, inspection and certification company and a member of the S&P/ASX 200 industrials sector. Its Business is running laboratories that analyse samples — rock and soil for miners searching for and monitoring deposits, water and soil for environmental clients, and food, pharmaceuticals and other materials for life-sciences customers. How laboratory testing connects ALS to Mining and environmental spending is the crux of the company: its revenue rises and falls with how much its clients spend on exploration, monitoring and testing, making it a barometer of activity across mining and other industries.

The FY2026 result, for the year ended 31 March 2026, was a record, driven by strong Demand in its commodities-testing business and steady growth in life sciences.

A record result

ALS reported total revenue of A$3,320.1 million, up 10.7%, and underlying net profit after tax of A$381.2 million, up 25.8%, with underlying EBIT of A$599.0 million, up 19.3%. Statutory net profit was A$318.7 million. The board declared a full-year Dividend of 42.5 cents a share, a 57% payout of underlying profit.

The result reflected both revenue growth and Margin expansion, as the company grew its testing volumes and improved efficiency. Both of its main divisions contributed, but the standout was the Commodities business tied to mining.

Commodities: geared to mining

The Commodities division is ALS's most cyclical and highest-margin business, and it links the company directly to mining. It provides geochemical and metallurgical testing — analysing rock samples to determine what minerals they contain — for miners and explorers. When mining companies are actively exploring for new deposits and developing mines, they send large numbers of samples to ALS's laboratories for analysis, driving testing volumes and revenue.

In FY2026, Commodities revenue rose 18.8% to A$1,294.2 million, with underlying EBIT up 25.9% to A$381.5 million at a margin of 29.5%. Its minerals-testing margin reached 33.0%, above 30% for a fifth consecutive year. This performance reflected strong sample volumes as miners, buoyed by high prices for gold and other commodities, invested in exploration. Because exploration spending tracks Commodity prices and miner confidence, the Commodities division gives ALS clear exposure to the health of the mining sector.

Life Sciences: steadier growth

ALS's larger division by revenue is Life Sciences, which provides testing for environmental, food, pharmaceutical and consumer clients. This includes analysing water, soil and air for contamination, testing food for safety and quality, and supporting pharmaceutical and other industries. In FY2026 Life Sciences generated revenue of A$2,025.9 million, up 6.0%, with underlying EBIT of A$296.5 million, up 10.2%, at a margin of 14.6%.

Environmental testing links ALS to spending on monitoring and compliance, which is driven by regulation, infrastructure projects and industrial activity, and tends to be steadier than mining exploration. This division provides a more stable, recurring base of revenue that balances the cyclicality of Commodities. Together, the two divisions give ALS exposure to both the ups and downs of mining and the steadier demand for environmental and life-sciences testing.

Why testing is a good business

Testing is an attractive business for several reasons. It is essential — miners must test samples to know what they have, and environmental and food testing is often required by regulation — so demand is durable. It benefits from scale, since a large network of laboratories is expensive to replicate, and much of the work is recurring, particularly in environmental and food testing.

ALS's global network, technical expertise and reputation give it strong positions in its markets. The high margins in its minerals business, and the steady growth in life sciences, reflect the value of trusted testing. As industries face growing requirements to monitor, test and certify — whether for exploration, environmental compliance or product safety — demand for ALS's services is supported over the long term.

The risks

The main cyclical risk lies in the Commodities division. Mineral-exploration spending is tied to commodity prices and miner confidence, and a downturn would reduce sample volumes and hit this high-margin business, as has happened in past cycles. The strong FY2026 result rested partly on buoyant commodity prices supporting exploration; a Reversal would be a headwind.

Life Sciences is steadier but competitive, and margins are lower. ALS operates globally, exposing it to currency movements, and it must keep investing in laboratories, technology and acquisitions to grow. Cost Inflation in labour and other inputs can pressure margins. The company also carries the operational and reputational risks of a testing business, where accuracy and integrity are paramount. Acquisitions, a part of its growth, carry execution risk. Broad economic conditions affect demand across its end-markets.

A quality testing franchise

Despite the cyclicality of its mining exposure, ALS is a high-quality business with strong positions in essential testing markets, a global network, and a balance between cyclical, high-margin commodities testing and steadier environmental and life-sciences work. The record FY2026 result — strong revenue growth and expanding margins across both divisions — reflects the strength of the franchise.